Amneal Pharmaceuticals (AMRX) Cash & Equivalents (QoQ) (2017 - 2026)
Amneal Pharmaceuticals (AMRX) Cash & Equivalents (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Amneal Pharmaceuticals | 4.84 Bn | 4.84 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.52% |
| Dec 31, 2025 | 712.13% |
| Sep 30, 2025 | -51.46% |
| Jun 30, 2025 | 986.80% |
| Mar 31, 2025 | -16.67% |
| Dec 31, 2024 | 82.07% |
| Sep 30, 2024 | -90.09% |
| Jun 30, 2024 | 758.72% |
| Mar 31, 2024 | -32.62% |
| Dec 31, 2023 | -91.30% |
| Sep 30, 2023 | -20.46% |
| Jun 30, 2023 | 1,608.90% |
| Mar 31, 2023 | -75.38% |
| Dec 31, 2022 | 203.60% |
| Sep 30, 2022 | 37.93% |
| Jun 30, 2022 | -97.05% |
| Mar 31, 2022 | 2,251.96% |
| Dec 31, 2021 | 12.37% |
| Sep 30, 2021 | -97.14% |
| Jun 30, 2021 | 7,387.38% |